Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
Bioequivalence study is proposed to be carried out on patients of ovarian cancer, who are
already receiving or who in the opinion of their treating physicians are candidates for
Doxorubicin liposomal injection therapy .